A detailed history of Allen Investment Management LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Allen Investment Management LLC holds 8,060 shares of ABBV stock, worth $1.33 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
8,060
Previous 8,060 -0.0%
Holding current value
$1.33 Million
Previous $1.38 Million 15.12%
% of portfolio
0.02%
Previous 0.02%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

SELL
$154.79 - $180.76 $5,417 - $6,326
-35 Reduced 0.43%
8,060 $1.38 Million
Q3 2023

Nov 13, 2023

BUY
$133.59 - $154.65 $8,015 - $9,279
60 Added 0.75%
8,095 $1.21 Million
Q4 2022

Feb 10, 2023

SELL
$138.31 - $165.87 $34,162 - $40,969
-247 Reduced 2.98%
8,035 $1.3 Million
Q1 2021

May 17, 2021

SELL
$102.3 - $112.62 $123,476 - $135,932
-1,207 Reduced 12.72%
8,282 $896,000
Q4 2020

Feb 03, 2021

BUY
$80.49 - $108.67 $68,094 - $91,934
846 Added 9.79%
9,489 $1.02 Million
Q3 2020

Nov 03, 2020

BUY
$85.91 - $100.83 $34,020 - $39,928
396 Added 4.8%
8,643 $757,000
Q1 2020

May 07, 2020

BUY
$64.5 - $97.79 $15,931 - $24,154
247 Added 3.09%
8,247 $628,000
Q3 2019

Nov 06, 2019

SELL
$62.98 - $75.72 $30,671 - $36,875
-487 Reduced 5.74%
8,000 $606,000
Q2 2019

Aug 12, 2019

SELL
$65.7 - $83.98 $14,256 - $18,223
-217 Reduced 2.49%
8,487 $617,000
Q4 2018

Feb 05, 2019

BUY
$77.85 - $96.01 $15,569 - $19,202
200 Added 2.35%
8,704 $802,000
Q4 2017

Feb 13, 2018

SELL
$89.56 - $98.21 $93,052 - $102,040
-1,039 Reduced 10.89%
8,504 $822,000
Q3 2017

Nov 07, 2017

BUY
$69.85 - $89.22 $73,761 - $94,216
1,056 Added 12.44%
9,543 $848,000
Q2 2016

Sep 22, 2017

SELL
N/A
-60 Reduced 0.7%
8,487 $525,000
Q3 2015

Sep 22, 2017

SELL
N/A
-4,788 Reduced 35.91%
8,547 $465,000
Q2 2015

Sep 22, 2017

BUY
N/A
4,727 Added 54.91%
13,335 $896,000
Q1 2015

Sep 22, 2017

SELL
N/A
-623 Reduced 6.75%
8,608 $504,000
Q4 2014

Sep 22, 2017

BUY
N/A
9,231
9,231 $604,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $292B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Allen Investment Management LLC Portfolio

Follow Allen Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allen Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allen Investment Management LLC with notifications on news.